Swiss Re loses another SFr819 million on two CDSs

Zürich-based reinsurer Swiss Re announced it had booked a mark-to-market loss of SFr819 million ($781 million) on two portfolio credit default swaps (CDSs) in its first-quarter results on May 6, and warned that it was likely to lose another SFr200 million on the trades during April.

The same trades, referencing a trading portfolio that includes US subprime mortgages, were also responsible for a SFr1.2 billion loss at the reinsurer in November last year. This brings the total damage done by the two contracts to over SFr2 billion.

The portfolio CDSs were structured for a single unnamed client in 2006 and 2007, with a total notional value of SFr5.12 billion. They reference a trading portfolio of mortgage-backed assets managed by a third party, including residential and commercial mortgage-backed securities and collateralised debt obligations of asset-backed securities.

The trades were designed to attach at super-senior level and have an economic lifespan of five years, according to Swiss Re. The firm said the positions were in run-off, implying it is still exposed to assets already in the underlying portfolio but will not take exposure to any new assets.

As of October 2007, the company stated the mark-to-market value of the portfolio was 68.4% of its par value. By March 31, it had depreciated to 53.9% of par, causing a further mark-to-market loss.

The portfolio CDSs appeared to be largely responsible for a 53% decline in net revenue at Swiss Re from the same quarter in 2007, to SFr624 million.

A spokesman for the reinsurer reiterated a statement made by chief executive Jacques Aigrain in November last year, saying: “We took immediate action to strengthen our risk-taking and we are not writing any additional structured credit derivatives transactions.”

See also: Swiss Re admits $1.07 billion loss on two portfolio CDSs

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here